Pharmacogenomics : methods and protocols
著者
書誌事項
Pharmacogenomics : methods and protocols
(Methods in molecular biology / John M. Walker, series editor, v. 1015)(Springer protocols)
Humana Press, c2013
2nd ed
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Understanding an individual's genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy. Based upon the success of its first edition, the second edition of Pharmacogenomics: Methods And Protocols aims to continue providing readers with high-quality content on the most innovative and commonly adopted technologies in the field of pharmacogenomics as presented by experts in the field. Broken into several sections, this detailed volume examines techniques for interrogating variation in human genes and genomes, functional assessment of genetic variation, both in vitro and in vivo, as well as tools for translation and implementation of pharmacogenetic markers. Written in the highly successful Methods in Molecular Biology (TM) series format, chapters include introductions to the respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls.
Comprehensive and thoroughly updated, Pharmacogenomics: Methods And Protocols, Second Edition serves as an essential reference and an invaluable source on the latest information in this field.
目次
Part I: Introduction to Pharmacogenomics
1. Pharmacogenomics: Historical Perspective and Current Status
Rosane Charlab and Lei Zhang
Part II: Techniques for Interrogating Variation in Human Genes and Genomes
2. Denaturing High-Performance Liquid Chromatography for Mutation Detection and Genotyping
Donna Lee Fackenthal, Pei Xian Chen, Ted Howe, and Soma Das
3. Clinical SNP Detection by the SmartAmp Method
Toshihisa Ishikawa and Yoshihide Hayashizaki
4. MALDI-TOF Mass Spectrometry
Dirk van den Boom, Matthias Wjst, and Robin Everts
5. TaqMan (R) Drug Metabolism Genotyping Assays for the Detection of Human Polymorphisms Involved in Drug Metabolism
Toinette Hartshorne
6. Pyrosequencing of Clinically Relevant Polymorphisms
Cristi R. King and Sharon Marsh
7. Pharmacogenetics Using Luminex (R) xMAP (R) Technology: Method for Developing a Custom Multiplex Single Nucleotide Polymorphism Mutation Assay
Gonnie Spierings and Sherry A. Dunbar
8. Use of Linkage Analysis, Genome-Wide Association Studies, and Next-Generation Sequencing in the Identification of Disease-Causing Mutations
Eric Londin, Priyanka Yadav, Saul Surrey, Larry J. Kricka, and Paolo Fortina
9. The GoldenGate Genotyping Assay: Custom Design, Processing, and Data Analysis
Anna Gonzalez-Neira
10. Genome-Wide Gene Expression Profiling, Genotyping, and Copy Number Analyses of Acute Myeloid Leukemia Using Affymetrix GeneChips
Mathijs A. Sanders and Peter J.M. Valk
11. Epigenetic Techniques in Pharmacogenetics
Sandra G. Heil
12. Plasmid Derived External Quality Controls for Genetic Testing
Tahar van der Straaten and Henk-Jan Guchelaar
Part III: Functional Assessment of Genetic Variation: In Vitro and In Vivo Methods
13. Allelic Imbalance Assays to Quantify Allele-Specific Gene Expression and Transcription Factor Binding
Francesca Luca and Anna Di Rienzo
14. SCAN: A Systems Biology Approach to Pharmacogenomic Discovery
Eric R. Gamazon, R. Stephanie Huang, and Nancy J. Cox
15. Methods to Examine the Impact of Nonsynonymous SNPs on Protein Degradation and Function of Human ABC Transporter
Toshihisa Ishikawa, Kanako Wakabayashi-Nakao, and Hiroshi Nakagawa
16. In Vitro Identification of Cytochrome P450 Enzymes Responsible for Drug Metabolism
Zhengyin Yan and Gary W. Caldwell
17. In Vitro and In Vivo Mouse Models for Pharmacogenetic Studies
Amber Frick, Oscar Suzuki, Natasha Butz, Emmanuel Chan, and Tim Wiltshire
18. The Hydrodynamic Tail Vein Assay as a Tool for the Study of Liver Promoters and Enhancers
Mee J. Kim and Nadav Ahituv
Part IV: Tools for Translation and Implementation of Pharmacogenetic Markers
19. A Guide to the Current Web-Based Resources in Pharmacogenomics
Dylan M. Glubb, Steven W. Paugh, Ron H.N. van Schaik, and Federico Innocenti
20. PharmGKB: The Pharmacogenomics Knowledge Base
Caroline F. Thorn, Teri E. Klein, and Russ B. Altman
21. Genetic Databases in Pharmacogenomics: The Frequency of Inherited Disorders Database (FINDbase)
Marianthi Georgitsi and George P. Patrinos
22. Development of Predictive Models for Estimating Warfarin Maintenance Dose Based on Genetic and Clinical Factors
Lu Yang and Mark W. Linder
23. Evidence Based Drug Dosing and Pharmacotherapeutic Recommendations Per Genotype
Vera H.M. Deneer and Ron H.N. van Schaik on behalf of the Dutch Pharmacogenetics Working Group
「Nielsen BookData」 より